127 related articles for article (PubMed ID: 37182504)
41. Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine.
Ram N; Aroui S; Jaumain E; Bichraoui H; Mabrouk K; Ronjat M; Lortat-Jacob H; De Waard M
J Biol Chem; 2008 Aug; 283(35):24274-84. PubMed ID: 18603532
[TBL] [Abstract][Full Text] [Related]
42. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
Farrugia BL; Lord MS; Melrose J; Whitelock JM
Molecules; 2015 Mar; 20(3):4254-76. PubMed ID: 25751786
[TBL] [Abstract][Full Text] [Related]
43. Chemistry of heparitin sulfate and heparin from normal tissues and from patients with Hunter syndrome.
Nader HB; Cohen DM; Dietrich CP
Biochim Biophys Acta; 1979 Jan; 582(1):33-43. PubMed ID: 153768
[TBL] [Abstract][Full Text] [Related]
44. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
45. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.
Koenig A; Norgard-Sumnicht K; Linhardt R; Varki A
J Clin Invest; 1998 Feb; 101(4):877-89. PubMed ID: 9466983
[TBL] [Abstract][Full Text] [Related]
46. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
47. The relevance of glycosaminoglycan sulfates to Apo E induced lipid uptake by hepatocyte monolayers.
Oswald B; Shelburne F; Landis B; Linker A; Quarfordt S
Biochem Biophys Res Commun; 1986 Nov; 141(1):158-64. PubMed ID: 2948501
[TBL] [Abstract][Full Text] [Related]
48. Systematic protein interactome analysis of glycosaminoglycans revealed YcbS as a novel bacterial virulence factor.
Hsiao FS; Sutandy FR; Syu GD; Chen YW; Lin JM; Chen CS
Sci Rep; 2016 Jun; 6():28425. PubMed ID: 27323865
[TBL] [Abstract][Full Text] [Related]
49. Effect of pathological conditions on peritoneal macrophage glycosaminoglycans: Impact on cytoadherence.
Gowd V; Sandeep MS; Chilkunda DN
Int J Biol Macromol; 2016 Nov; 92():1183-1190. PubMed ID: 27519294
[TBL] [Abstract][Full Text] [Related]
50. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
51. Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation.
Almeida PC; Nantes IL; Chagas JR; Rizzi CC; Faljoni-Alario A; Carmona E; Juliano L; Nader HB; Tersariol IL
J Biol Chem; 2001 Jan; 276(2):944-51. PubMed ID: 11016923
[TBL] [Abstract][Full Text] [Related]
52. Heparinase II from Flavobacterium heparinum. Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis.
Shriver Z; Hu Y; Sasisekharan R
J Biol Chem; 1998 Apr; 273(17):10160-7. PubMed ID: 9553064
[TBL] [Abstract][Full Text] [Related]
53. Glycosaminoglycans modulate cell-matrix interactions of human fibroblasts and endothelial cells in vitro.
Schaefer T; Roux M; Stuhlsatz HW; Herken R; Coulomb B; Krieg T; Smola H
J Cell Sci; 1996 Feb; 109 ( Pt 2)():479-88. PubMed ID: 8838671
[TBL] [Abstract][Full Text] [Related]
54. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
[TBL] [Abstract][Full Text] [Related]
55. Porcine Circovirus 2 Uses a Multitude of Weak Binding Sites To Interact with Heparan Sulfate, and the Interactions Do Not Follow the Symmetry of the Capsid.
Dhindwal S; Avila B; Feng S; Khayat R
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602608
[TBL] [Abstract][Full Text] [Related]
56. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix.
Shuvaev VV; Laffont I; Siest G
FEBS Lett; 1999 Oct; 459(3):353-7. PubMed ID: 10526164
[TBL] [Abstract][Full Text] [Related]
57. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
[TBL] [Abstract][Full Text] [Related]
58. Heparan Sulfate in the Tumor Microenvironment.
Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
[TBL] [Abstract][Full Text] [Related]
59. Substitution-inert polynuclear platinum complexes and Glycosaminoglycans: A molecular dynamics study of its non-covalent interactions.
Rosa NMP; Ferreira FHDC; Farrell NP; Costa LAS
J Inorg Biochem; 2022 Jul; 232():111811. PubMed ID: 35367819
[TBL] [Abstract][Full Text] [Related]
60. Sulfated Glycosaminoglycans as Viral Decoy Receptors for Human Adenovirus Type 37.
Chandra N; Liu Y; Liu JX; Frängsmyr L; Wu N; Silva LM; Lindström M; Chai W; Pedrosa Domellöf F; Feizi T; Arnberg N
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
